Marks Group Wealth Management »

Ascendis Pharma AS shares owned by Marks Group Wealth Management

Quarter-by-quarter ownership of Ascendis Pharma AS (ASND) shares owned by Marks Group Wealth Management from 13F filings

Historical chart of Marks Group Wealth Management investment in Ascendis Pharma AS

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma AS held by Marks Group Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma AS by Marks Group Wealth Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.2M 4.3k 266.72

More positions owned by Marks Group Wealth Management

Spdr Series Trust St Str P500etf (SPYM)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Eafe Grwth Etf (EFG)
Apple (AAPL)
Putnam Etf Trust Focused Lar Cap (PVAL)
Blackrock Etf Trust Isha I In Te Etf (BAI)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Eafe Value Etf (EFV)
Ishares Core Msci Emkt (IEMG)
Fidelity Covington Trust Momentum Factr (FDMO)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
Invesco Exch Traded Fd Tr Ii S&p Intl Qulty (IDHQ)
Blackrock Etf Trust Isha La Core Etf (BLCR)
NVIDIA Corporation (NVDA)

View all positions for Marks Group Wealth Management

Top funds holding Ascendis Pharma AS

T. Rowe Price Associates
A.R. Schmeidler & Co
New York State Common Retirement Fund
Driehaus Capital Management
Q Global Advisors
Sapient Capital
Tudor Investment Corporation
Handelsbanken Fonder AB
Diversified Trust Company
Henry James International Management
Sterling Capital Management
Mediolanum International Funds
China Universal Asset Management
Evolutionary Tree Capital Management
Gilbert & Cook

View all funds holding Ascendis Pharma AS